Harrow Enterprise Value Multiple from 2010 to 2024

HROW Stock  USD 40.02  1.84  4.40%   
Harrow Health Enterprise Value Multiple yearly trend continues to be fairly stable with very little volatility. Enterprise Value Multiple is likely to outpace its year average in 2024. During the period from 2010 to 2024, Harrow Health Enterprise Value Multiple regression line of quarterly data had r-squared of  0.19 and coefficient of variation of (505.98). View All Fundamentals
 
Enterprise Value Multiple  
First Reported
2010-12-31
Previous Quarter
49.54488351
Current Value
52.02
Quarterly Volatility
138.70275277
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as Interest Expense of 22.4 M, Selling General Administrative of 87.2 M or Selling And Marketing Expenses of 37.7 M, as well as many indicators such as Price To Sales Ratio of 2.67, Dividend Yield of 6.0E-4 or PTB Ratio of 4.9. Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.
  
Check out the analysis of Harrow Health Correlation against competitors.
For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

Latest Harrow Health's Enterprise Value Multiple Growth Pattern

Below is the plot of the Enterprise Value Multiple of Harrow Health over the last few years. It is Harrow Health's Enterprise Value Multiple historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harrow Health's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Multiple10 Years Trend
Slightly volatile
   Enterprise Value Multiple   
       Timeline  

Harrow Enterprise Value Multiple Regression Statistics

Arithmetic Mean(27.41)
Coefficient Of Variation(505.98)
Mean Deviation77.21
Median(4.35)
Standard Deviation138.70
Sample Variance19,238
Range628
R-Value0.43
Mean Square Error16,808
R-Squared0.19
Significance0.11
Slope13.47
Total Sum of Squares269,338

Harrow Enterprise Value Multiple History

2024 52.02
2023 49.54
2022 -129.01
2021 -26.32
2020 56.45
2019 148.2
2018 -52.71

About Harrow Health Financial Statements

Harrow Health investors use historical fundamental indicators, such as Harrow Health's Enterprise Value Multiple, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harrow Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Multiple 49.54  52.02 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.